by US Rx Care | Aug 20, 2019 | Uncategorized
A new report by Sun Life Insurance Co. highlights the top high-cost claim conditions that plague the U.S. health care system and account for more than half of all catastrophic or unpredictable claims costs. The top 10 costliest claim conditions comprised over half...
by US Rx Care | Aug 13, 2019 | Uncategorized
The IRS has announced new health savings account contribution maximums for the 2020 health insurance plan year. Employees who have an HSA linked to a high-deductible health plan (HDHP) will be able to contribute to their HSA up to a certain level to help pay for...
by US Rx Care | Aug 8, 2019 | Uncategorized
In 2015, spending on prescription drugs grew 9%, faster than any other category of health care spending, according to the U.S. Centers for Medicare and Medicaid Services. The report cited increased use of new medicines, price increases for existing ones, and more...
by US Rx Care | Jul 30, 2019 | Uncategorized
The Senate Health Committee in May 2019 released a draft bill that aims to reduce health care costs, taking particular aim at the lack of transparency in the system and the scourge of surprise medical bills. The draft legislation is the first serious attempt at...
by Renzo Luzzatti | Jul 23, 2019 | Uncategorized
The heat is growing on the pharmaceutical industry after more than 40 US states filed a lawsuit accusing generic drug makers of engaging in a massive price-fixing scheme. The lawsuit accuses 20 companies of conspiring to fix prices of more than 100 generic drugs,...
by Renzo Luzzatti | Jul 16, 2019 | Uncategorized
As more people struggle with their medical bills, Congress has been introducing a raft of new legislation aimed at cutting costs and making pricing more transparent. The multi-pronged, bipartisan effort targets the lack of transparency in pricing particularly for...
by Renzo Luzzatti | Jul 15, 2019 | Uncategorized
Retail prescription drug spending grew 36% over the four-year period ended Dec. 31, 2016, but out-of-pocket spending for health plan enrollees remained steady, according to a recent study by the Pew Charitable Trusts. The study, “The Prescription Drug Landscape,...
by US Rx Care | Jul 3, 2019 | Uncategorized
The Trump administration has issued new rules that would allow employers to provide workers with funds in health reimbursement accounts (HRAs) that can be used to purchase health insurance on the individual market. The rule reverses a long-standing part of the...
by US Rx Care | Jun 25, 2019 | Uncategorized
The Centers for Medicare and Medicaid Services has floated proposed regulations that would affect drug benefits for group plans and association plans and attempt to reduce drug expenses for health plan enrollees and drug plans. While the rules seem to be focused on...
by US Rx Care | Jun 18, 2019 | Uncategorized
President Trump has signed two bills into law that would add transparency to drug pricing by banning gag clauses imposed by pharmacy benefit managers (PBMs) that bar pharmacists from discussing drug prices with the person buying prescription medication. The bills,...
